SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-022977
Filing Date
2013-04-19
Accepted
2013-04-19 21:51:48
Documents
1
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 rrd377294.html 5  
1 FORM 5 rrd377294.xml 5 3783
  Complete submission text file 0001181431-13-022977.txt   5429
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address
Martignetti Anthony (Reporting) CIK: 0001574697 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-14895 | Film No.: 13772627